Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v7-FR
Language English French
Date Updated 2024-09-28 2024-08-09
Drug Identification Number 02469405 02469405
Brand name PREVYMIS PREVYMIS
Common or Proper name Letermovir for injection Letermovir for injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients LETERMOVIR LETERMOVIR
Strength(s) 20MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1 x Vial 1 x Vial
ATC code J05AX J05AX
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2024-08-12 2024-08-12
Actual start date 2024-08-08 2024-08-08
Estimated end date 2024-10-04 2024-10-04
Actual end date 2024-09-27
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments PREVYMIS SFI 240MG VIAL, PREVYMIS 240MG 4X7TAB & PREVYMIS 480MG 4X7TAB formats remain available. PREVYMIS SFI 240MG VIAL, PREVYMIS 240MG 4X7TAB & PREVYMIS 480MG 4X7TAB formats remain available.
Health Canada comments